In some embodiments, the formulations or compositions described herein have a pH between about 5 and about 8, or between about 6 and about 7, or between about 6.5 and about 7, or between about 5.5 and about 7.5, or between about 7.1 and about 7.7, and have a concentration of active pharmaceutical ingredient between about 50 and about 80 mM
65,66 Single-nucleotide polymorphisms in GH-related genes are associated with the risk of developing osteosarcoma, breast, and colon cancer
Unlike full GH, AOD-9604 does not stimulate IGF-1 production, which means it avoids several risks associated with traditional growth hormone therapy including increased cancer risk, fluid retention, carpal tunnel syndrome, and metabolic complications
inject near the affected joint
From the preclinical data for putative benefits there were also important side effects noted
The molecular basis for the prolonged blood circulation of lipidated incretin peptides :peptide oligomerization or binding to serum albumin